第16卷第8期
2006年 4月
中国现代医学杂志
China Jourual of Modern Medicine
Vo1.16 No.8
Apr.2006
文章编号: 1005—8982(2006)08—1 130—05
Analgesia on pancreatic carclnom a wRll cllemical destruction ● ’ ● - ■ ● l l ● - - ●
.' ’ ‘ ’ · · l - - -·
0t celiac ganglion Dy ultrasonic intervention
WANG Tap,TIAN Fu-zhou,CAI Zhong—hong,LI Xu,SHI Li,CHEN Tap,CHEN Qi
(Department of Generd Surgery,Chengdu Army,Chengdu,Sichuan 610083,P.R.China)
Abstract: 【Objeetive】To detect the therapeutic effects of chemical destruction of celiac ganglion on patients
tll pancreatic carcinoma with intractable pain.【Methods】97 cases with advanced pancreatic carcinoma accepted
chemical destruction of celiac gan~ion——1 5 mL pure alcohol i~ection around celiac a~ery by ultrasonic inter—
vention. nle varieties of VAS,sevtlm SP,B—EP and T—lymphocyte subtypes level were compared between pre—and
post-therapy.【Results】Successful rate of puncture was 98.7%,with 1 loss.No serious complications such as trau-
matic pancreatitis,pancreatic fistula,abdominal cavity hemorrhage or peritoneal infection in this study.VAS,sevtlm
SP and 13-EP level significantly changed after treatment <0.01,P<0.05 and P<0.o1),with complete relief rate
54.2%,partial relief rate 21.9%,inefficient ratel2.5% and recurrent rate only 10.7%. rhe T—lymphocyte subtypes
level remarkably increased when compared with that of pre—therapy <0.oa).【Conclusion】This study suggests
that chemical destruction of celiac ganglion by ultrasonic intervention proves to be highly safe, and can evidently
relieve cancer pain of pancreas and improve the cellular immune level on patients with advanced pancreatic carci—
nom a.
Key words:ultrasonic intervention;analgesia chemical destruction;pancreatic carcinoma;celiac ganglion
CI C number:R81 Document code:A
超声介入腹腔神经节毁损治疗胰腺癌疼痛
汪 涛,田伏州1,蔡忠红,李
(成都军区总医院全军普外
旭,石 力,陈 涛,陈 琪
中心,四川 成都 61 0083)
摘要:目的 探讨超声介导腹腔神经节毁损对胰腺癌痛患者的治疗作用。方法 97例胰腺癌痛患者采用
B超引导经皮穿刺,于腹腔动脉干根部旁侧注入无水乙醇15mL,实施腹腔神经节化学性毁损。对比观察治疗
前后疼痛的视觉模拟评分(VAS)、血清sP和 B-EP以及T细胞亚群水平变化。结果 97例中仅1例穿刺失
败,成功率98,7%,无严重并发症;VAS、血清sP和 B-EP与术前差异有显著性(P
表达
cells there were enzymes of androgen synthesis but no
aromatase expression. But our experiment shows that
aromatase is located in interstltial cells of endometrial
adenocarcinoma. Estrogens synthesized by these tis-
sues can act on tumor cells by paracrine and promote
tumor growth. The latent factors in tumor for regular—
ing aromatase expression are not clear yet. It is sup—
posed that the macrophages,lymphocytes and carcino-
ma cells stimulate endometrium to produce PG and
other cytokines, and then activate cAMP pathway to
regulate the expression of aromatase.Therefore,com—
bined usage of aromatase protein, ER, PR and Ki67
detection can be the marker of early diagnosis, pre—
dicting endocrine therapy and estimating prognosis.It
also provided a new theoretic evidence for the usage
of aromatase inhibitory in endocrine therapy of en—
dometria】carcinoma.
References:
[1】KATSUMIT,SATOSHI M,YUTAKAS,et a1.Identification and char-
acterlzation of transcriptional regulatory elements of the human aro-
matase cytochrome P450 gene[JJ. J Steroid Biochem Molec Biol,
1996,56(1):151-159.
[2】KITARVAKI J,KOSHIBA H,ISHIHARA H,et a1.Progesterone in-